Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
BMJ Global Health|January 7, 2022
Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosisChristiaan Mulder, Stephan Rupert, Ery Setiawan, et al.Plos One|April 21, 2025
Acceptability of broadly neutralizing antibodies (bNAbs) for HIV prevention among vulnerable populations in India: Findings from a qualitative studyJoyeeta Mukherjee, Saif Ul Hadi, Venkatesan Chakrapani, et al.Plos Medicine|January 24, 2023
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling studyAllison Portnoy, Rebecca A Clark, Matthew Quaife, et al.The Lancet. Global Health|March 16, 2023
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling studyRebecca A Clark, Christinah Mukandavire, Allison Portnoy, et al.Plos One|March 19, 2025
Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdensChristopher Alba, Shelly Malhotra, Stephanie Horsfall, et al.Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling studyChristopher Alba, Shelly Malhotra, Stephanie Horsfall, et al.Pageof 2